SCHEMBL19081704

SCHEMBL19081704

c1ccc2c(c1)ccc1c2oc2c(-c3c4ccccc4c(-c4ccc5oc6ccccc6c5c4)c4ccccc34)cc3c4ccccc4oc3c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
MAPT P10636 4/20 0.37
HPGD P15428 4/20 0.37
TSHR P16473 3/20 0.37
HSD17B10 Q99714 3/20 0.37
ALDH1A1 P00352 3/20 0.37
ALOX15 P16050 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
CYP1A1 P04798 11/20 0.36
CYP1B1 Q16678 10/20 0.36
CYP1A2 P05177 10/20 0.36
ABCG2 Q9UNQ0 3/20 0.36
MAPK1 P28482 2/20 0.36
ABCB1 P08183 2/20 0.36
ABCC1 P33527 2/20 0.36
PRKDC P78527 2/20 0.36
PDE5A O76074 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944904 0.88 MAPT (0.41) KDM4EMAPTHPGDHSD17B10ALDH1A1
SCHEMBL10122608 0.87 CYP1A1 (0.43) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL21687085 0.87 ALOX5 (0.40) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL20127668 0.87 KDM4E (0.38) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL19081695 0.87 CYP1A1 (0.40) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL19081692 0.86 CYP1A1 (0.38) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL20127677 0.86 L3MBTL1 (0.40) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL17122576 0.85 CYP1A1 (0.43) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL19109886 0.84 ALOX5 (0.39) KDM4EMAPTHPGDALDH1A1CYP1A2
SCHEMBL22546776 0.84 ALOX5 (0.38) KDM4EMAPTHPGDTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 KDM4E 3720/4885MAPT 1294/4885HPGD 1859/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 KDM4E 3720/4885MAPT 1294/4885HPGD 1859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.